These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25612283)

  • 1. [Systemic Adamantiades-Behçet's disease: adverse effects of an otherwise successful therapy with interferon-α-2a].
    Karagiannidis I; Zouboulis CC
    Dtsch Med Wochenschr; 2015 Jan; 140(2):112-3. PubMed ID: 25612283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.
    Krause L; Altenburg A; Pleyer U; Köhler AK; Zouboulis CC; Foerster MH
    J Rheumatol; 2008 May; 35(5):896-903. PubMed ID: 18412306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Adamantiades-Behçet disease with systemic interferon alfa.
    Zouboulis CC; Orfanos CE
    Arch Dermatol; 1998 Aug; 134(8):1010-6. PubMed ID: 9722733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuro-Behçet syndrome presenting as acute meningeal syndrome.
    Kara B; Somer A; Pişkin S; Aydinli N; Salman N; Yalçin I
    J Infect; 2006 Apr; 52(4):e120-3. PubMed ID: 16197999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.
    Park JY; Chung YR; Lee K; Song JH; Lee ES
    Yonsei Med J; 2015 Jul; 56(4):1158-62. PubMed ID: 26069144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease.
    Krause L; Turnbull JR; Torun N; Pleyer U; Zouboulis CC; Foerster MH
    Adv Exp Med Biol; 2003; 528():511-9. PubMed ID: 12918754
    [No Abstract]   [Full Text] [Related]  

  • 8. New approaches in the treatment of Adamantiades-Behçet's disease.
    Pipitone N; Olivieri I; Cantini F; Triolo G; Salvarani C
    Curr Opin Rheumatol; 2006 Jan; 18(1):3-9. PubMed ID: 16344613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adamantiades-Behçet disease. Therapeutic administration of systemic recombinant interferon-alpha-2a].
    Zouboulis CC; Treudler R; Orfanos CE
    Hautarzt; 1993 Jul; 44(7):440-5. PubMed ID: 8365878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjunctival ulcers in Behçet's disease.
    Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
    Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.
    Bodaghi B; Gendron G; Wechsler B; Terrada C; Cassoux N; Huong du LT; Lemaitre C; Fradeau C; LeHoang P; Piette JC
    Br J Ophthalmol; 2007 Mar; 91(3):335-9. PubMed ID: 17050581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.
    Kötter I; Eckstein AK; Stübiger N; Zierhut M
    Br J Ophthalmol; 1998 May; 82(5):488-94. PubMed ID: 9713053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behçet's disease--a contemporary review.
    Mendes D; Correia M; Barbedo M; Vaio T; Mota M; Gonçalves O; Valente J
    J Autoimmun; 2009; 32(3-4):178-88. PubMed ID: 19324519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behçet's disease: a case report.
    Krause L; Hoffmann F; Zouboulis CC; Foerster MH
    Graefes Arch Clin Exp Ophthalmol; 2003 Oct; 241(10):871-4. PubMed ID: 13680252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients.
    Lee JH; Lee CS; Lee SC
    BMC Ophthalmol; 2018 Feb; 18(1):52. PubMed ID: 29463220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behcet's disease and its oral manifestations.
    Georgaklis CC
    Dent Today; 2004 Jun; 23(6):92-5. PubMed ID: 15218677
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet's disease.
    Kavandi H; Khabbazi A; Kolahi S; Hajialilo M; Shayan FK; Oliaei M
    Clin Rheumatol; 2016 Nov; 35(11):2765-2769. PubMed ID: 27234230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alfa-2a in the treatment of Behçet's disease.
    Azizlerli G; Sarica R; Köse A; Ovül C; Kavala M; Kayabali M; Erkan F; Kural Z
    Dermatology; 1996; 192(3):239-41. PubMed ID: 8726638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal venous thrombosis in Behcet's disease.
    Jafri L; Nasir N; Almas A
    J Coll Physicians Surg Pak; 2012 Nov; 22(11):730-2. PubMed ID: 23146858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha 2a treatment of neuro-Behcet disease.
    Nichols JC; Ince A; Akduman L; Mann ES
    J Neuroophthalmol; 2001 Jun; 21(2):109-11. PubMed ID: 11450899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.